#PHARMA: Want to invest in the new Berkshire Hathaway for Health Care?

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is ‘unique’. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI.

‘PDL allows investors to derisk and invest in a portfolio of products and companies’ says Mr Garcia. ‘We recently bought a company and bought a drug to put into that company. We don’t do research and development ourselves. We acquire income streams’.

PDL BioPharma seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries.

This interview is one of a series with Edison pharma clients shot at the Biotech and Money Conference at the Waldorf Hotel, London on 14.11.2017.

Share via
Copy link
Malcare WordPress Security